Shandong Jincheng Pharmaceutical Group: The first phase of the employee stock ownership plan has been fully sold.

Shandong Jincheng Pharmaceutical Group announced that all company stocks held under the first phase of the employee stock ownership plan have been fully sold. This stock ownership plan was approved by the shareholders' meeting on September 28, 2023, and through the concentrated competitive bidding on the secondary market, a total of 1.6153 million shares of company stock were bought, accounting for 0.42% of the company's total share capital. The duration of the stock ownership plan is 24 months, with a lock-up period of 12 months. As of the date of this announcement, all 1.6153 million shares held by the stock ownership plan have been fully sold, the implementation of the stock ownership plan has been completed and terminated, and the management committee will proceed with the clearing of related assets and distribute them according to the shareholding of the holders.